别名:IMP; BRAP2; RNF52.应用:WB
反应种属:Human
规格:50μl/100μl
| Description |
|---|
| Negatively regulates MAP kinase activation by limiting the formation of Raf/MEK complexes probably by inactivation of the KSR1 scaffold protein. |
| Specification | |
|---|---|
| Aliases | IMP; BRAP2; RNF52. |
| Entrez GeneID | 8315 |
| Swissprot | Q7Z569 |
| clone | 6D3 |
| WB Predicted band size | Calculated MW: 67 kDa; Observed MW: 67 kDa |
| Host/Isotype | Mouse IgG1 |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Purified recombinant human BRAP protein fragments expressed in E.coli. |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3. |
| Application | |
|---|---|
| WB | 1/500-1/1000 |
![]() |
Western blot analysis of BRAP in CHO-K1 lysates, transfected with a Human pFLAGCMV2BRAP construct (A) or transfected with a Human pFLAGCMV2 construct (B), using BRAP antibody. |
![]() |
Western blot analysis of BRAP in A549 and HUVEC lysates using BRAP antibody. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
中文


发表回复